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DOI 10.1016/j.stem.2011.11.005SUMMARY Seijffers et al., 2010; Rabbani et al., 2011), bone morphogeneticHair follicle (HF) regeneration begins when communi-
cation between quiescent epithelial stem cells (SCs)
and underlying mesenchymal dermal papillae (DP)
generates sufficient activating cues to overcome
repressive BMP signals from surrounding niche cells.
Here, we uncover a hitherto unrecognized DP trans-
mitter, TGF-b2, which activates Smad2/3 transiently
in HFSCs concomitant with entry into tissue regener-
ation. This signaling is critical: HFSCs that cannot
sense TGF-b exhibit significant delays in HF regener-
ation, whereas exogenous TGF-b2 stimulates HFSCs
in vivo and in vitro. By engineering TGF-b- and BMP-
reporter mice, we show that TGF-b2 signaling antag-
onizes BMP signaling in HFSCs but not through
competition for limiting Smad4-coactivator. Rather,
our microarray, molecular, and genetic studies unveil
Tmeff1 as a direct TGF-b2/Smad2/3 target gene, ex-
pressed by activated HFSCs and physiologically
relevant in restricting and lowering BMP thresholds
in the niche. Connecting BMP activity to an SC’s
response to TGF-bs may explain why these signaling
factors wield such diverse cellular effects.
INTRODUCTION
Tissue homeostasis and regeneration are regulated through
balancing quiescence and activation of SCs. HFs offer a unique
opportunity to explore this process. Throughout adult life, they
undergo dynamic, synchronized cycles of degeneration (cata-
gen), quiescence (telogen), and regeneration (anagen) (Millar,
2002; Schmidt-Ullrich and Paus, 2005; Blanpain and Fuchs,
2009). During telogen, which can last for months, HFSCs are
quiescent and reside within a specialized microenvironment
called the bulge (Cotsarelis et al., 1990).Within this niche, HFSCs
surround the hair shaft produced in the previous cycle.
Throughout telogen, the base of the bulge, called the secondary
hair germ (HG), directly abuts the underlying DP, a key signaling
center for HFSCs.
The telogen/anagen transition relies upon DP-HFSC cross-
talk to generate the necessary threshold of activating factors.
In addition to Wnt-activating cues (Greco et al., 2009; Enshell-protein (BMP) inhibitory factors play a central role in the anagen-
promoting process (Kulessa et al., 2000; Botchkarev et al., 2001;
Zhang et al., 2006). Upon activation, HFSCs in the HG are the
first to proliferate and initiate HF regeneration, whereas HFSCs
within the bulge become active several days later (Greco et al.,
2009).
As the new HF emerges, the DP stimulus is pushed increas-
ingly further from niche SCs, which return to quiescence (Hsu
et al., 2011). By contrast, throughout anagen, relatively undiffer-
entiated bulge cell progeny along the outer root sheath (ORS)
accelerate proliferation as they approach the DP. This fuels
a steady production of transiently amplifying (TA) matrix cells,
which undergo a few divisions while in contact with DP and
then terminally differentiate to form the hair and inner root
sheath (IRS). At the anagen/catagen transition, matrix cells
apoptose and the DP retracts upward along with the dying/
differentiating epithelial strand. As the HF reenters telogen,
BMPs from the inner layer of non-SC niche cells (Hsu et al.,
2011) and from surrounding dermal tissue (Plikus et al., 2008)
impose a threshold, which must be overcome to initiate the
next cycle.
BMPs belong to a superfamily that includes transforming
growth factor bs (TGF-bs). TGF-bs function in tissuemorphogen-
esis, homeostasis, and cancer by regulating diverse biological
processes including proliferation, apoptosis, differentiation,
and extracellular matrix (ECM) production (Siegel and Mas-
sague´, 2003). Skin epithelial cells express distinct Ser/Thr kinase
receptors for both BMP and TGF-b pathways. These differen-
tially propagate their respective signals by phosphorylating
Smad1/5/8 (BMP) or Smad2/3 (TGF-b), which form distinct
bipartite transcription factors with Smad4 (ten Dijke and Arthur,
2007). Although BMP’s inhibitory effects are well documented,
the effects of TGF-b signaling on HFSCs remains largely
unexplored.
TGF-bs potently inhibit proliferation of interfollicular epidermis
(IFE), and postnatal loss of TGF-b signaling renders skin prone to
tumorigenesis (Bierie and Moses, 2006; Guasch et al., 2007;
Massague´, 2008). Conditional loss of TGF-b receptor II
(TbRII-cKO) results in loss of canonical TGF-b signaling in the
skin epithelium, but overall tissue morphology remains intact
(Guasch et al., 2007). Intriguingly, full gene knockout studies of
the receptor ligands show three different effects on embryonic
HF development: delay (TGFb2), enhancement (TGFb1), or
none (TGFb3) (Foitzik et al., 1999). Given these complexities,
we turned to the following key questions. Do TGF-bs playCell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc. 63
Figure 1. TGF-b Signaling Is Transiently Activated
in HFSCs at the Telogen/Anagen Transition of the
New Hair Cycle
(A) pSmad2 and CD34 immunolocalizations in HFs during
the first telogen/anagen transition; telogen (postnatal
day 21, P21), anagen I (P22), and anagen II (P23). Note two
distinct sites of pSmad2 staining (arrowheads). Black
asterisks denote autofluorescence (not immunostaining)
on the hair shaft.
(B) Time-course monitoring of pSmad2 and P-cadherin
(Pcad) during the extended second telogen and into the
next anagen. White asterisks denote low but real pSmad2
in bulge HFSCs.
(C) pSmad2 and Ki67 coemerge upon HFSC activation.
TGF-b signaling is transient and wanes after the telogen/
anagen transition.
(D) Lentiviral TGF-b-reporter. H2B-CFP driven by
a constitutively active PGK promoter is used as a viral
infection marker; NLS-mRFP reports TGF-b-pSmad2
signaling.
(E) Validation of the TGF-b-reporter in 1MK cultured from
WT and TbRII-cKO skins. Note that reporter activity
occurs only if TbRII is intact and cells are stimulated with
TGF-b2.
(F) Verification that canonical TGF-b signaling (NLS-
mRFP+; arrowheads) occurs in HG SCs during late (P74)
telogen. The TGF-b-reporter was transduced specifically
into the surface epithelium by in utero infection of live E9.5
embryos.
Dashed lines denote dermal-epidermal border; solid lines
delineate the DP. Blue channel is DAPI staining. Scale bars
represent 50 mm. See also Figure S1.
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are involved, which cells transmit the signals, and what cells
are affected? How might TGF-b signaling within the niche influ-
ence the balance between HFSC quiescence and activation,
and by what mechanism? Here we address these points and in
so doing, shed important new light on the signaling crosstalk
within the SC niche.
RESULTS
TGF-b Signaling Is Transiently Activated in Stem Cells
during the Telogen/Anagen Transition
To determine whether and how TGF-bs might affect HF regener-
ation, we first verified the specificity of our anti-phospho-Smad2
antibodies. Upon TGF-b exposure in vitro, primary wild-type
(WT) mouse epidermal keratinocytes (1MKs) exhibit phosphor-
ylation and nuclear translocation of Smad2, which can be de-
tected by immunoblotting of nuclear extracts and immunofluo-
rescence. This band and nuclear staining were absent in the
equivalent 1MKs from Tgfbr2fl/fl;Tg(KRT14-Cre)1Efu (TbRII-
cKO) mice whose skin epithelium lacks TbRII, an essential
component of the TGF-b receptor (Figures S1A and S1B avail-
able online; Guasch et al., 2007). Using WT and TbRII-cKO
mice, we then turned to in vivo analyses.
During normal homeostasis, epidermis displayed little or no
signs of active TGF-b signaling (not shown). Postnatally, the first
signs of TGF-b signaling appeared in telogen, when pSmad2+
nuclei were detected in HG cells adjacent to the DP (Figure 1A).64 Cell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc.As follicles began cycling, nuclear pSmad2+ cells also appeared
in CD34+ HFSCs at the bulge base. By the time full anagen was
reached, pSmad2 immunofluorescence was no longer detected
in HFSCs (Figure S1C).
The second telogen (marked by two rather than one club hairs)
lasted about 4 weeks in control mice. During early and mid-telo-
gen phases, TGF-b activity was weak. As telogen ended,
pSmad2 reappeared in the P-cadherin+ HG and lower bulge (Fig-
ure 1B). Notably, pSmad2 was detected 5 days before this
proliferative activity was seen within the HG (Figure 1C). Similar
to the first hair cycle, most HG cells in early anagen exhibited
TGF-b signaling, but as the expanding HG engulfed the DP and
formed the matrix, pSmad2 waned.
To further examine TGF-b signaling, we engineered a lenti-
virus harboring a canonical TGF-b-reporter driven by Smad2/
3-Smad4 binding sites (Figure 1D). In vitro, reporter expression
(NLS-mRFP+) was detected only in TGF-b-stimulated, trans-
duced (H2B-CFP+) 1MKs from WT and not in TbRII-cKO
mice (Figure 1E; shown are data for TGF-b2). When trans-
duced by in utero infection into embryonic skin epithelium
(Beronja et al., 2010) and then monitored in adult mice, the
TGF-b-reporter was active selectively in the WT HG, beginning
at late telogen and continuing into early anagen (Figure 1F).
Underscoring reporter specificity, similarly transduced TbRII-
cKO animals showed no signs of reporter activity. These
data revealed that nuclear pSmad2 at the telogen/anagen
transition is accompanied by pSmad2-mediated active tran-
scription in the HG.
Figure 2. Micewhose Skin Epithelium IsDeficient in TGF-bSignaling
Show a Delay in HFSC Activation and Hair Cycle Entry
(A) Immunolocalization of Ki67 and pSmad2 in WT and TbRII-cKO mice (P22).
Dashed and solid lines outline HFSC bulge/HG niche and DP, respectively.
QuantificationofKi67+HGcells (n=5,R96HGcells ineachmice) shownat right.
(B and C) Hair coats of pairs of WT and TbRII-cKO mice were clipped in mid-
second telogen (P52) and then photographed periodically thereafter and
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TGF-b Signaling Is Lost
The TGF-b/pSmad2 signaling pattern upon anagen onset paral-
leled the two-step activation of HFSCs described previously
(Greco et al., 2009). To determine whether TGF-b signaling func-
tions in HFSC activation, we analyzed this process in TbRII-cKO
mice. By 22 days, control HFs had already entered the first ana-
gen and showed proliferating (Ki67+) HG cells, while TbRII-cKO
HFswere still in telogen (Figure 2A). Because the firstWT telogen
lasts only 1–2 days, the phenotypic consequences of losing
TGF-b signaling to SC activation and tissue regeneration were
best visualized by waiting until HFs had entered the extended
second telogen. At this time, we clipped hair coats of sex-
matched littermates and then followed the emergence of new
hairs as the next cycle began (Figure 2B).
In the second telogen, hair growth was so delayed in TbRII-
cKO mice that 75% coat recovery occurred 1 month later
than normal (Figure 2C). Despite this delay, the final lengths of
the four hair types were normal (Figure 2D), as were HFmorphol-
ogies and established markers (Figure 2E). Thus, once TbRII-
deficient SCs were eventually activated, they executed what
appeared to be an otherwise normal hair cycle.
The Dermal Papillae Produce a Paracrine TGF-b2 Signal
to Activate Canonical TGF-b-Mediated Transcription
in Hair Follicle Stem Cells
Because pSmad2+ cells appeared at the interface between HG
and DP, and after the extended crosstalk period that is required
for HFSC activation, we sought to identify the TGF-b ligands
involved and the cell population expressing them. A survey of ex-
istingmicroarray data indicated that in adult skin, TGFb2mRNAs
might be enriched in DP relative to HG or HFSCs (Greco et al.,
2009). Support for this came from real-time quantitative poly-
merase chain reaction (RT-qPCR) of mRNAs isolated from puri-
fied cell populations of late-telogen phase, Lef1-RFP transgenic
skins. TGFb2 mRNAs selectively were enriched in DP relative to
other IFE and HF populations, whereas TGFb1 and TGFb3
mRNA expression was low and showed no specific enrichment
(Figures 3A and S2A).
Immunofluorescence analyses were consistent with these
findings. Of the three TGF-bs, only TGF-b2 protein appeared in
HFs toward the end of telogen (Figures 3B and S2B). Intercellular
TGF-b2 first accumulated at the ECM interface between DP and
HG, but by anagen onset, it intensified in the DP, with weaker
staining in HGs. Although latent TGF-b complexes can reside
within ECM (ten Dijke and Arthur, 2007), TGF-b2 signal intensity
in the DP coincided with nuclear pSmad2 in the HG.
To test whether TGF-b2 signaling can precociously activate
resting HFSCs, we coinjected recombinant, active TGF-b2 withcategorized according to 25%, 50%, or 75% recovery. WT, n = 9; TbRII-cKO,
n = 8 (n stands formouse number). Note that hair coat recovery inWTmice was
nearly complete by P125, but in TbRII-cKO-matched littermates, recovery still
often lagged even at P172. Box-and-whisker plots: mid-line, median; box, 25th
and 75th percentiles; whiskers, minimum and maximum.
(D) Analysis of the four types of hairs plucked at telogen (Guard, n = 10; Awl,
nR 21; Auchene, nR 16; and Zigzag, nR 20).
(E) Immunolocalizations of bulge-specific CD34 and bulge/HG marker Lhx2 in
telogen-phase HFs. Data are mean ± SEM.
Scale bars represent 50 mm.
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Figure 3. TGF-b2 Is Produced by DP, Activates pSmad2 in HFSCs, and Participates in the Telogen/Anagen Transition
(A) RT-qPCR on mRNAs from IFE, HG, bulge, and DP cells FACS purified from Lef1-RFP and TbRII-Het/Rosa26YFP HFs in late telogen (P70).
(B) Immunolocalization of TGF-b2 and pSmad2 at the DP-HG interface is low through mid-telogen (P56) but elevates in late (P65) telogen through early anagen
(Ana I, P72). Note: late-telogen HF with strongest TGF-b2 in DP shows highest pSmad2 in HG (arrowhead versus arrow). Dashed lines denote dermal-epidermal
border.
(C–E) Precocious activation of telogen/anagen occurs when TGF-b2-soaked fluorescent beads are injected intradermally.
(C) (Top) Experimental strategy. TGF-b2 or BSA was coinjected with blue or red fluorescent beads intradermally at days 1–3, followed by BrdU administration at
D4 and analysis at days 5, 8, or 20. (Middle) TGF-b2 accelerates BrdU immunodetection in WT, but not TbRII-cKO HG. (Right) Magnified views of boxed areas.
(Bottom) Quantifications of BrdU incorporation into HG (Pcad+), bulge (CD34+), and IFE (K5+ other) cells from mice injected with either BSA (n = 6) or TGF-b2
(nR 6). Box-and-whisker plots: mid-line, median; box, 25th and 75th percentiles; whiskers, minimum and maximum.
(D) Ki67 immunolabeling of skin sections from (E). Vertical line denotes boundary between telogen and anagenWT HFs, correlating with bead (TGF-b2) density in
the vicinity.
(E) Surface views of TGF-b2-injected areas at D20. Precocious hair growth was observed only on WT skin. Dashed circle indicates still barren injection site on
TbRII-cKO animal. Data are mean ± SEM.
Scale bars represent 50 mm. See also Figure S2.
Cell Stem Cell
TGF-b Antagonizes BMP Signaling in Stem Cell Nichefluorescent beads into mid-telogen skin dermis, i.e., well before
the normal appearance of endogenous TGF-b2 in DP (see exper-
imental design in Figure 3B). In TbRII-heterozygous (WT) mice,
TGF-b2 injections resulted in Smad2 phosphorylation not only
in the HG, but also in IFE and some dermal cells (Figure S2C).
By contrast, TbRII-cKO skin epithelium was refractory to TGF-
b2-mediated Smad2 activation, while dermal cells responded.
This result indicated that the effects of DP-derived TGF-b2 on
precocious pSmad2 induction rely upon the HG’s ability to
respond through the canonical receptors. With our TGF-
b-reporter mice, we further demonstrated that the signaling66 Cell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc.involves canonical pSmad2-mediated transcriptional activation
(Figure S2D).
TGF-b2 Induces Proliferation in Quiescent Hair Follicle
Stem Cells and Propels Them into a Tissue-
Regenerating Mode
Bromodeoxyuridine (BrdU) administration and S-phase cell
quantification revealed that HGs of WT HFs reacted to TGF-b2
by displaying both nuclear pSmad2 and proliferation (Figures
3C and S2C). Although this further substantiated the sequential
order of events we had observed in the normal hair cycle (see
Figure 4. TGF-b Stimulates Colony Formation of Primary HFSCs In Vitro and Dampens BMP Signaling in HFSCs In Vivo
(A) Immunolocalizations of pSmad1/5/8 in early (P48), mid (P59), and late (P72) second-telogen WT (TbRII-Het) and TbRII-cKO HFs. Note that nuclear
pSmad1/5/8 (BMP signaling) wanes in late-telogen WT but not TbRII-cKO HFs.
(B) Bulge SCs were FACS purified from telogen-phase HFs, plated, and allowed to grow for 2 weeks in media supplemented with TGF-b2 or BMP4 at
concentrations indicated. Quantifications of colony numbers and sizes are shown below.
(C and D) Colony formation assays on HFSCs from (C) WT and TbRII-cKO or (D)Bmpr1a-cKOHFs exposed to TGF-b2 (10 pM) and/or BMP4 (1.0 nM) for 2 weeks.
Quantifications of (C, D) colony sizes and (D) numbers are shown right.
(E) BSA, Noggin, or TGF-b2 was coinjected with green fluorescent beads intradermally into TbRII-Het/WT and cKO mice in mid-telogen (P58–P60), and then
examined for BMP signaling (anti-pSmad1/5/8) in HFSCs.
(F) Quantifications of BrdU incorporated into HG cells near the sites of bead injections. BrdU was administered intraperitoneally for 24 hr after the intradermal
injections of BSA, Noggin, or TGF-b2 at early (P48–P50, n = 4) and mid (P58–P60, n = 4–13) telogen and the telogen/anagen transition (P73–P75, n = 5).
(G) Quantifications of BrdU incorporated into HG cells near the injection sites (nR 6). Blue channel is DAPI. Dashed lines denote dermal-epidermal border.
Data are mean ± SEM. Box-and-whisker plots: mid-line, median; box, 25th and 75th percentiles; whiskers, minimum and maximum. ***p < 0.001, **p < 0.01,
*p < 0.05. Scale bars represent 50 mm. See also Figure S3.
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growth effects on epidermal cells, which was also reflected in
decreased BrdU incorporation within IFE (Figure 3C). These
results indicate that IFE and HF progenitors interpret TGF-b2
differently and further underscore the specificity of the prolifera-
tive response of HFSCs to TGF-b2.
TGF-b2’s stimulatory effects depended upon close prox-
imity of HFs to the bead injection site and were followed by
a precocious hair cycle (Figures 3D, 3E, S2E, and S2F). This
differed from similar injections with FGF7, another DP-derived
factor that stimulated HG proliferation, but did not kindle
a new hair cycle (Greco et al., 2009). Taken together, our find-
ings indicate that in normal homeostasis, DP utilizes TGF-b2 in
short-range signaling to stimulate HFSCs at the bulge base.
The outcome is canonical TGF-b receptor/pSmad2 transcrip-
tion that in some way enables them to achieve the activating
threshold necessary to flip the telogen/anagen transition
switch.BMP Signaling Is Prolonged when Hair Follicle Stem
Cells Cannot Respond to TGF-b2
Throughout the resting phase, high BMP signaling maintains
HFSCs in a quiescent state and must be overcome to promote
new tissue growth (Andl et al., 2004; Blanpain et al., 2004; Kobie-
lak et al., 2007; Plikus et al., 2008; Rendl et al., 2008; Greco et al.,
2009; Hsu et al., 2011). The appearance of TGF-b2 protein in the
DP toward the end of telogen coincided with the timing of
enhanced mRNAs encoding DP-derived BMP inhibitory factors,
including Sostdc1 and Bambi (Greco et al., 2009). Given the
seemingly opposing effects of TGF-b2 and BMPs on HFSC
quiescence, we wondered whether TGF-b2 might be impacting
the BMP pathway, and if so how.
To address this possibility, we first evaluated the conse-
quences of loss of TGF-b signaling on BMP receptor signaling
in HFSCs (Figure 4A). In WT HFSCs, nuclear anti-phospho-
Smad1/5/8 immunostaining, a sign of active BMP signaling,
was observed throughout early and mid-telogen, but wanedCell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc. 67
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pSmad2 (Figure 4A; see also Figure 1B). However, in TbRII-
cKO HFSCs, pSmad1/5/8 remained high throughout this time
(Figure 4A), consistent with the notion that TGF-b signaling nega-
tively affects BMP signaling.
To further explore TGF-b2’s effects, we cultured epidermal
1MKs, where the antiproliferative effects of TGF-bs are well es-
tablished (Siegel and Massague´, 2003). Indeed, all three TGF-bs
promoted comparable Smad2 phosphorylation and induced
growth arrest in amonophasic, dose-dependent fashion (Figures
S3A–S3E). Consistent with its lower binding affinity to TbRII
(Cheifetz et al., 1987; Massague´ et al., 1992), 103 more
TGF-b2 (10 versus 1 pM)was necessary to achieve growth inhibi-
tion (Figure S3E). Recombinant TGF-bs had no effects on TbRII-
cKO 1MKs, thereby confirming the specificity of the response.
Next, we tested cultured HFSCs, purified by fluorescence-
activated cell sorting (FACS) of mid-telogen HFs (Figure 4B). At
higher concentrations (50–100 pM), TGF-bs reduced both
number and size of HFSC colonies. However, at lower concen-
trations (10 pM) where epidermal 1MKs were still growth
restricted, HFSC colonies grew larger. This effect was highly
reproducible and not seen in TbRII-null HFSCs (Figure 4C). In
good agreement with our in vivo observations, these results
further unveiled the dose dependency of TGF-b’s stimulatory
effects on HFSCs.
Consistent with HFSC quiescence in and out of the niche
in vivo, nuclear pSmad1/5/8 staining was also greater in nascent
colonies of HFSCs than in 1MKs (Figure S3F). This was true for
both WT and TbRII-null cells, but not Bmpr1a-cKO cells, which
showed no signs of BMP signaling. Moreover, pSmad1/5/8
staining in WT HFSCs was reduced by exposure to TGF-b2
(Figure S3G).
Further substantiating the antagonistic effects of TGF-b2 on
the BMP pathway, we found that BMP4’s effects were mono-
phasic and could be partially relieved by TGF-b2 in a TbRII-
dependent manner (Figures 4B and 4C). Importantly, neither
BMP4 nor TGF-b2 affected the colony size in Bmpr1a-cKO
HFSCs (Figure 4D). Moreover, even though TGF-b2 on its
own no longer exerted effects on colony size as HFSCs
were passaged, TGF-b2 still counteracted the negative effects
of BMPs that were added exogenously to HFSC cultures (Fig-
ure S3H). Thus, the stimulatory growth effects of TGF-bs ap-
peared to be restricted to cells exhibiting active BMP
signaling.
To further pursue the notion that TGF-b2 acts positively to
overcome BMP inhibitory thresholds and activate HFSCs, we
compared TGF-b2’s effects to Noggin, an established and
potent BMP antagonist (Botchkarev et al., 2001; Plikus et al.,
2008). In early telogen, neither Noggin nor TGF-b2 were suffi-
cient to overpower the exceedingly high BMPs within the
HFSC niche and dermis. However, in mid-telogen, both Noggin
and TGF-b2 precociously diminished nuclear pSmad1/5/8 and
induced HG proliferation (Figures 4E and 4F). As endogenous
TGF-b2 signaling and BMP signaling blockers rose and dermal
BMP waves waned at telogen’s end, these effects were less
pronounced. Notably, although probably not physiologically
relevant, TGF-b1 and TGF-b3 behaved similarly, indicating that
it is TGF-b availability and not TGF-b2 per se that is important
in the process (Figure 4G).68 Cell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc.In contrast to Noggin, TGF-b2’s effects were seen only in WT
and not TbRII-cKO mice. This result was important as it demon-
strated that the opposing effects of TGF-b2 onBMP signaling are
mediated directly through the TGF-b receptor pathway rather
than cross-counter effects on their respective receptors. More-
over, these data provided compelling complementary evidence
that the atypically long telogen of TbRII-cKO mice arises from
protracted BMP signaling in HFSCs.
Evidence Favoring a TGF-b Target Gene in Hair Follicle
Stem Cell Activation
To further probe the antagonistic interaction between TGF-b2
and BMP signaling, we engineered and tested a BMP-reporter
lentivirus (Figure 5A). In vitro, transduced WT and TbRII-null,
but not Bmpr1a-null, 1MKs displayed BMP-reporter activity in
response to BMP4. In vivo, WT HFSCs showed concomitant
downregulation of both BMP-reporter activity and pSmad1/5/8
at telogen’s end. By contrast, TbRII-cKO HFSCs sustained
BMP-reporter activity and pSmad1/5/8 during this time.
Importantly, our BMP-reporter was specific, and in the
absence of BMPs, TGF-b2 had little or no effect on its expression
(Figure 5B). In contrast, BMP4 strongly stimulated BMP-reporter
(ZsGreen) expression. TGF-b2 dampened this activity specifi-
cally in WT and not in TbRII-cKO 1MKs. Moreover, similar
results were obtained with cultured, FACS-purified HFSCs.
However, HFSCs displayed active BMP signaling in vitro, and
hence TGF-b2 alone was sufficient to reduce BMP-reporter
activity in HFSCs (Figure 5C). Based upon these results,
TGF-b2 appeared to counteract not only extrinsic but also
intrinsic BMP signaling.
The dampening effects on BMP signaling were paralleled at
the mRNA level and appeared relatively late (12–24 hr) after
TGF-b2 treatment (Figure 5D). With 1MK, this effect was even
more obvious when they were pretreated with TGF-b2 prior to
adding BMP4 (Figure 5E). Because the reporter differs from
control vector only by multimerized Smad1/5/8 binding sites,
these results further bolstered the notion that TGF-b2 was
specifically affecting canonical BMP signaling at the transcrip-
tional level.
One way of achieving these effects might be through compe-
tition between pSmad2/3 and pSmad1/5/8 for a limiting amount
of the Smad4 cofactor. Such mechanisms should be refractory
to drugs such as cycloheximide, which effectively blocks protein
synthesis within minutes in epidermal keratinocytes (Rice and
Green, 1979). However, 10–100 mg/ml cycloheximide nearly
abrogated the inhibitory effects of TGF-b2 on BMP-reporter
expression (Figure 5F; shown are data for 10 mg/ml). Thus,
TGF-b2’s antagonistic effects appeared to require new protein
synthesis.
Further evidence against a Smad4 competition mechanism
came from testing whether simultaneous activation of Smad2/3
interfered with the availability of transcriptional cofactor Smad4
for Smad1/5/8. Immunoblot analysis of nuclear and cytoplasmic
lysates from TGF-b2, BMP, and TGF-b2/BMP-costimulated
(short-term) cells showed that BMP4 stimulated phosphorylation
and nuclear accumulation of Smad1/5/8 and that this did not
change upon TGF-b2 costimulation (Figure 5G). Conversely,
TGF-b2-enhanced phosphorylation and nuclear accumulation
of Smad2/3 did not change with BMP4 costimulation. Notably,
Figure 5. Evidence Favoring a TGF-b Target Gene Mechanism for Dampening BMP Signaling rather than pSmad2/3-Mediated Competition
for Limiting Smad4
(A) Lentiviral BMP-reporter. (In vitro) After BMP4 stimulation, BMP-reporter activity (green) is detected in 1MK from WT and TbRII-cKO, but not Bmpr1a-cKO
(Bmpr1afl/fl;K14-Cre) mice. (In vivo) BMP-reporter activity in HFs at mid (P58) and late (P74) telogen. Note that BMP-reporter activity fails to be downregulated in
TbRII-cKO HFs. Dashed lines, dermal-epidermal border; solid lines, DP; DAPI (blue).
(B–F) Lentiviral BMP-reporter-transduced 1MKs (B, D–F) or 1HFSCs from FACS-purified HGs (C) were plated and stimulated with BSA, TGF-b2, and/or BMP4
for 24 hr.
(B) Fixed cells were observed by direct-fluorescencemicroscopy. (Right) Quantifications of ZsGreen fluorescence intensity in H2B-CFP+ cells (n = 10,R370H2B-
CFP+ cells were measured at the same exposure time).
(C–F) RT-qPCR analyses of ZsGreenmRNA levels. Lentiviral BMP-reporter-transduced cells were stimulated with BMP4 ± TGF-b2 for either 24 hr (C) or indicated
times (D–F), and BMP-reporter activities were quantified by ZsGreen mRNA levels.
(E) Cells ± TGF-b2 pretreatment for 18 hr were stimulated with BMP4 for indicated times.
(F) Cells were plated in the presence of BMP4 ± TGF-b2, and cycloheximide (10 or 100 mM) was then added for indicated times. Data shown are for 10 mM
cycloheximide, but similar results were obtained with 100 mM.
(G) Immunoblot analyses of nuclear (N) and cytoplasmic (C) fractions from 1MK treated with TGF-b2 and/or BMP4. Nuclear control: anti-Lamin A/C; cytoplasmic
control: anti-IkBa.
(H) Coimmunoprecipitation of endogenous Smad4 and Smad1 in TGF-b2 and/or BMP4-treated 1MK. Complexes (IP) and whole cell extracts (WCE) were
analyzed by immunoblotting with the indicated antibodies.
Data are mean ± SEM. ***p < 0.001, *p < 0.05. Scale bars represent 50 mm.
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Cell Stem Cell
TGF-b Antagonizes BMP Signaling in Stem Cell Nichealthough nuclear:cytoplasmic ratios of Smad4 increased upon
BMP4/TGF-b2 costimulation, there appeared to be ample
Smad4 to accommodate both pathways. This was further
demonstrated by coimmunoprecipitating Smad4 with Smad1
antibodies. As shown in Figure 5H, complex levels were not
diminished by BMP4/TGF-b2 costimulation.
A Search for Relevant TGF-b Target Genes Yields
Tmeff1, Encoding an Antagonist of the BMP Pathway
In searching for an alternative transcriptional mechanism that
could explain TGF-b2’s antagonistic effects on BMP signaling,
we wondered whether one of pSmad2/3-Smad4’s target genes
might encode a negative regulator of BMP signaling. To test
this hypothesis, we purified and transcriptionally profiled HFSC
mRNAs at times prior to and during peak TGF-b2 expression in
the DP.
Microarray profiling and comparative analyses were per-
formed on duplicate sets of HG (YFP+Pcadhi), bulge HFSCs
(YFP+ CD34+), and total (YFP+) cells FACS-purified from two
pairs of late-telogen/early-anagen female TbRII-Het (WT) and
cKO littermates (Figures S4A and S4B). As expected, the HGdis-
played more changes over these times than the other cell popu-
lations. Concomitant with TGF-b2 expression, 341 probes (292
genes) were specifically elevated byR23 in the WT HG relative
to the bulge or total YFP+ cells. Shown in Table S1, this ‘‘acti-
vated HG signature’’ differed from prior HG array data (Greco
et al., 2009) in that it was rich in, e.g., cell cycle genes associated
with stem cell activation.
In comparing ‘‘preactivated’’ TbRII-null and WT HGs, only 40
of these genes were downregulated in TbRII-null HGs. By
contrast, in comparing their ‘‘activated’’ states, 252 genes
were downregulated by R23 in the TbRII-null HG (Table S2),
and 239 of these were among the ‘‘activated HG signature.’’
Although some changes could bemore closely linked to HG acti-
vation and not specifically to the absence of TGF-b2 signaling,
63 of these genes have evolutionally conserved Smad2/3-
Smad4 sequence motifs within the body of the gene or
5,000 bp 50 upstream (ECR browser [Ovcharenko et al., 2004])
(Table S3).
Several interesting findings emerged from these comparisons
(Figures 6A, S4C, and S5D). TbRII ablation did not affect the
master transcription factors required for HFSC/HG mainte-
nance. This was true even for Nfatc1, which is known to play
a role in HFSC quiescence downstream of BMP signaling (Hors-
ley et al., 2008). Rather, genes relating to (1) BMP inhibition, (2)
cell cycle stimulation, and (3) HF lineage-associated transcrip-
tion were featured among the genes downregulated in late-telo-
gen/early-anagen TbRII-cKO versus WT HG. Notably and in
contrast to cell cycle genes, inhibitors of BMP signaling re-
mained on the shortlist of putative TGF-b target genes: Bambi
(4.53), Bmper (3.73), and Tmeff1 (6.73).
After validating the microarray data by RT-qPCR, we exam-
ined temporal expression of BMP inhibitor genes after TGF-b2
stimulation in vitro (Figures 6B and 6C).Bambi has been reported
as a direct target of TGF-b-Smad signaling (Sekiya et al., 2004)
and has previously been identified as a possible participant in
DP-HG crosstalk (Greco et al., 2009). However, of the three,
Tmeff1 mRNA was not only the sixth most changed putative
TGF-b target gene in the TbRII-cKOHG signature, but it also dis-70 Cell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc.played more pronounced and sustained induction upon TGF-b2
treatment (Figure 6C). Therefore, we focused on this hitherto
unexplored gene in skin for our remaining studies.
To test whether Tmeff1’s putative Smad2/3 binding site is
indeed utilized, we conducted chromatin immunoprecipitation
(ChIP) with Smad2/3 antibodies. Notably, Smad2/3 binding
was enriched on the 50 UTR of the Tmeff1 gene of WT but not
TbRII-null 1MK (Figure 6D). Moreover, this enrichment was
observed only when WT cells were stimulated with TGF-b2.
Further evidence linking Tmeff1 to TGF-b2 signaling came
from protein analyses, where Tmeff1 protein displayed kinetics
that paralleled Tmeff1 gene induction in vitro (Figure 6E). In vivo,
Tmeff1 protein appeared concomitantly with pSmad2+ cells in (1)
HGs activated during normal homeostasis and (2) HGs preco-
ciously activated upon intradermal TGF-b injections (Figures
6F, 6G, and S4E). Finally, when TbRII-cKO HFSCs eventually
initiated their next hair cycle, the activated HGs showed no signs
of either Tmeff1 or pSmad2 (Figures 6H, S4F, and S4G). These
findings link Tmeff1 directly to TGF-b2 signaling and not merely
SC activation.
Functional Evidence that Tmeff1 Lowers the BMP
Threshold for Stem Cell Activation
To investigate whether Tmeff1 is functionally relevant to the
TGF-b2-mediated downregulation of BMP signaling, we per-
formed lentiviral Tmeff1-shRNA-mediated gene knockdown
experiments in BMP-reporter-transduced 1MK. 1MK were
exposed to BMP4/TGF-b2 as before, so that control cells would
maintain TGF-b2 signaling-dependent suppression of BMP-
reporter activity. In striking contrast to scrambled-shRNA where
BMP-reporter (ZsGreen) remained silent, cells transduced with
Tmeff1-shRNA were green (Figure 7A). By contrast, albeit some-
what less effective at knocking down their targets, Bambi and
Bmper-shRNA were considerably less potent at rescuing
BMP-reporter activity (Figures S5A and S5B).
In BMP4/TGF-b2-treated cells transduced with Tmeff1-
shRNA, endogenous Tmeff1 expression was kept low, and
BMP-reporter activity remained elevated. In contrast, Tmeff1
levels did not affect TGF-b-reporter activity or Smad2
phosphorylation (Figures S5C and S5E). Moreover, Tmeff1
appeared to be a key mediator of the specific antagonistic
effects of TGF-b2 on BMP-reporter activity, because introducing
mCherry- or FLAG-tagged Tmeff1 into BMP4-stimulated cells
resulted in strong suppression of both Smad1/5/8 phosphoryla-
tion and BMP-reporter activity (Figures 7B, S5D, and S5F).
To assess the physiological relevance of Tmeff1, we employed
our powerful in utero lentiviral delivery system, which enables
stable, efficient, and selective shRNA-knockdown in skin epithe-
lium (Beronja et al., 2010).We transducedmice with two different
Tmeff1-shRNAs and a scrambled control shRNA. Both Tmeff1-
shRNAs behaved similarly, ruling out off-target effects. For the
purposes here, we show representative skin sections from
mice transduced with the most effective Tmeff1-shRNA.
At P21, when HFs were in their short first-telogen, Tmeff1
protein was detected only in HGs of scrambled-shRNA- and
not in HGs of Tmeff1-shRNA-transduced mice (Figure 7C).
When adult mice were shaved at the start of their first postnatal
anagen (P23–P24), scrambled-shRNA-transduced hair coats
regrew with kinetics similar to uninfected littermates, whereas
Figure 6. Tmeff1 Is a Direct Target Gene of TGF-b Signaling and Expresses in the Hair Germ at the Telogen/Anagen Transition
(A) Schematic summary of microarray analysis. Overlap between the activated HG signature and the list of genes downregulated byR23 in late-telogen/early-
anagen TbRII-cKO versus Het HGs. 63 of these genes (see representative examples at right) contain putative conserved Smad2/3 binding elements. Italicized
genes are among the 1,787 genes bound by Smad2/3 in TGF-b-stimulated HaCaT keratinocytes (Koinuma et al., 2009).
(B) RT-qPCR on independently derived in vivo mRNA samples.
(C) RT-qPCR on in vitro mRNAs from TbRII-Het and null 1MK stimulated with BSA, TGF-b2 (3 and 18 hr), BMP4 (3 hr), or Noggin (3 hr). Data are means ± SEM of
three independent experiments.
(D) Tmeff1 ChIP analyses with a Smad2/3 antibody in BSA- or TGF-b2-treated TbRII-Het and null 1MK. Each primer set was designed to encompass three
conserved Smad-binding motifs at the Tmeff1 locus as predicted by ECR Browser (Ovcharenko et al., 2004). Fold-enrichments of immunoprecipitated DNA
fragments are compared to a control intronic fragment with no predicted site (Chr5-Int2). Data are shown as means ± SEM of two independent experiments.
(E) Immunoblotting of lysates prepared from WT and TbRII-null 1MK stimulated with TGF-b2 for indicated times.
(F) Coimmunolocalization of Tmeff1 and pSmad2 specifically at late telogen (P74, arrowhead) and not early (P46) or mid (P58) telogen or early anagen (P80).
(G) Tmeff1 immunodetection (arrowhead) in skin sections of sites where BSA or TGF-b2 was coinjected with green fluorescent beads in mid-telogen skin.
(H) Immunodetection of Tmeff1 and Ki67 in the nearly 20 days delayed early anagen TbRII-cKOHF. Note that Tmeff1 expression is absent even though the HG has
initiated proliferation.
Dashed lines denote dermal-epidermal border; solid lines delineate the DP. Data are mean ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05. Scale bars represent 50 mm.
See also Figure S4.
Cell Stem Cell
TGF-b Antagonizes BMP Signaling in Stem Cell NicheTmeff1-shRNA-transduced animals exhibited a significant delay
in hair regrowth (Figures 7D and 7E). By P43, when scrambled-
shRNA-transduced HFs had already entered into their second-
telogen (two hairs/HF), Tmeff1-shRNA-transduced HFs were still
in the midst of their first anagen (Figure 7F). Although the extent
of these differences varied somewhat with individual infections,
the trend was consistent, underscoring Tmeff1 as a downstream
target of TGF-b signaling and important mediator of SC activa-
tion at the telogen/anagen transition.
DISCUSSION
TGF-b2: APlayer in the PositiveMesenchymal-Epithelial
Crosstalk that Leads to Stem Cell Activation
TGF-b2 was previously shown to be positively involved in HF
development during embryogenesis (Foitzik et al., 1999; Jamora
et al., 2005). Our studies not only extend this to the postnatal haircycle but further bolster the view set forth by Foitzik et al. (1999)
that the responsiveness to TGF-b2 might be different between
HFSCs and IFE keratinocytes. Even under the same culture
conditions where TGF-b2 showed a positive effect on HFSCs,
IFE 1MKs were still growth restricted, suggesting that intrinsic
features underlie these differences. Our results now show that
extrinsic and intrinsic BMP signaling is higher in HFSCs than
IFEs, constituting a physiological root of their strikingly different
responses to TGF-bs.
At the start of telogen, intradermal BMP levels are high but
then gradually decline (Plikus et al., 2008). Conversely, BMP
inhibitors produced by the DP rise over telogen, thereby
reducing the threshold that maintains SC quiescence. Our find-
ings now show that TGF-b2 features prominently in dampening
BMP signaling and facilitating HFSC activation. Because TbRII-
cKOmice eventually enter into the next hair cycle after an unusu-
ally prolonged telogen phase, we are able to draw two additionalCell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc. 71
Figure 7. Tmeff1 Mediates the Dampening Effect of TGF-b2 on BMP Signaling
(A) 1MK transduced for the BMP-reporter (H2B-CFP is transduction marker) were also transduced with lentivirus harboring either scrambled control or Tmeff1-
shRNAs (H2B-mRFP is transduction marker). Cells were then treated with BMP4 ± TGF-b2 for 24 hr. (Right) RT-qPCR of indicated mRNAs. FACS was used to
enrich for shRNA-infected BMP-reporter cells, which were then stimulated with BMP4 ± TGF-b2 for 24 hr.
(B) The BMP-reporter 1MK (H2B-CFP is transduction marker) were transfected with an expression vector encoding Tmeff1-mCherry and stimulated with BMP4
for 24 hr. Inset shows that some of the overexpressed Tmeff1-mCherry protein is at the membrane, consistent with the corresponding functional readout of
reduced BMP-reporter expression.
(C–F) Embryos were infected with Tmeff1-shRNA or scrambled control shRNA lentiviruses (H2B-mRFP+) at E9.5 and then analyzed as adult mice.
(C) Representative anti-Tmeff1 immunofluorescence sections of P21 skins. Merged green and red channels are at right. Dashed lines denote dermal-epidermal
border.
(D) Hair coats were shaved at the start of the first postnatal anagen and regrowth was monitored thereafter at times indicated. Note: scrambled and uninfected
(control) littermates were indistinguishable. Representative examples are shown, but some experimental variation was observed, presumably because of
variations in infection efficiency and/or relative timing of infection.
(E) Quantification of 50% hair coat recovery from data in (D). Scramble control, n = 6; Tmeff1-shRNA, n = 10 (n stands for mouse number).
Box-and-whisker plots: mid-line, median; box, 25th and 75th percentiles; whiskers, minimum and maximum.
(F) At P43, HFs transduced with the scrambled control had already entered the second telogen, while similar transductions but with a Tmeff1-shRNA virus
resulted in HFs that were still delayed in anagen of the first postnatal hair cycle.
Data are mean ± SEM. ***p < 0.001, **p < 0.01, *p < 0.05. Scale bars represent 50 mm. See also Figure S5.
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TGF-b Antagonizes BMP Signaling in Stem Cell Nicheimportant conclusions: first, that TGF-b2’s function is specific to
the SC activation step; and second, that SC activation is not gov-
erned by a single factor or cell type but rather is exquisitely sensi-
tive and responsive to the comprehensive environment of the
HFSC niche.
TheHFSCniche is also the residence formelanocyte stemcells
(MSCs), which depend upon TGF-b signaling for their mainte-72 Cell Stem Cell 10, 63–75, January 6, 2012 ª2012 Elsevier Inc.nance (Nishimura et al., 2010; Tanimura et al., 2011). TGF-b1/2
are present in the IRS cells that appear in early anagen (Tanimura
et al., 2011), and we confirmed that pSmad2 is expressed in
mature IRS (Figure S1C). However, our findings now add two
intriguing new facets to this equation: first, TGF-b2 signaling
acts in a short-range and concentration-dependent fashion, as
judged by our bead injection and in vitro experiments; and
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TGF-b Antagonizes BMP Signaling in Stem Cell Nichesecond,DP is themajor sourceof TGF-b2, expressed specifically
and transiently at the quiescence/activation transition. Given
that DP abuts both HG and MSCs at a stage when they both
become activated, it will be interesting in the future to see how
this dynamic interplay unfolds. Additionally, while our studies
have concentrated on our discovery that TGF-b2 signaling nega-
tively influences BMP signaling in the HFSCs, other signaling
pathways, e.g., Wnts and Shh, could be impacted either directly
or indirectly, and this could contribute to the TGF-b-related cell-
type differences that we and others have observed in the skin.
Antagonistic Crosstalk between TGF-b2 and BMP
Signaling and a Role for the Direct TGF-b Target Gene
Tmeff1
BMP signaling negatively regulates SC proliferation in many
niches including the bulge (Zhang et al., 2006; Kobielak et al.,
2007; Plikus et al., 2008) and intestinal crypt (Haramis et al.,
2004). In both of these cases, BMP signaling appears to
suppress Wnt signaling. Although there are multiple means of
antagonizing Wnt signaling through BMP signaling (He et al.,
2004; Jian et al., 2006; Liu et al., 2006; Zhang et al., 2006; Kobie-
lak et al., 2007), restricting BMP signaling appears to be a key
step in promoting SC activation for tissue regeneration. Our
discovery of a novel paracrine role for TGF-b2 in dampening
BMP signaling unearths a newfound and early importance for
TGF-bs at this critical crossroad in SC biology.
We were prompted to delve deeper into the underlying mech-
anisms when we realized that TGF-b2’s communication circuit is
launched just prior to anagen onset when HFSCs undergo acti-
vation and proliferaton. We initially speculated that competition
between pSmad1/5/8 and pSmad2/3 for limiting Smad4 might
underlie the antagonistic effects we observed. As negative
support for this hypothesis mounted, we turned to an alternative
hypothesis, namely that a direct Smad2/3 target gene(s) might
encode an inhibitor of BMP signaling.
Consistent with the tight link between TGF-b2 signaling and
SC activation, our microarray and comparative analyses of
late-telogen/early-anagen TbRII-cKO versus Het HGs strongly
overlapped with our activated HG signature. Even though
many of the shared differentially expressed genes possessed
Smad2/3-Smad4 binding motifs, the list was not particularly en-
riched for such genes, suggesting that only a few may be rele-
vant to TGF-b2’s antagonistic effects on BMP signaling. In this
regard, Tmeff1 (also known as tomoregulin-1) surfaced and
stayed at the forefront.
Tmeff1 is a transmembrane protein containing two follistatin
domains and an epidermal growth factor-like domain in its extra-
cellular region. Although comparatively little is known about this
protein, several tantalizing reports relate to our findings: first,
Tmeff1 blocks BMP2-mediated mesoderm induction in the
Xenopus embryo, and second, it inhibits signaling of another
TGF-b superfamily member, Nodal, through direct binding to
the Nodal coreceptor Cripto (Chang et al., 2003; Harms and
Chang, 2003). Finally, although the epithelial-mesenchymal tran-
sition gene Snail, important in embryonic HF morphogenesis
(Jamora et al., 2005), did not surface as a relevant TGF-b2 target
in the adult HFSC niche, it is intriguing that like Snail family
members, Tmeff1 is commonly upregulated during epithelial-
mesenchymal transitions (Moreno-Bueno et al., 2006).Our studies now demonstrate that Tmeff1 is a direct target of
TGF-b signaling. They also uncover a hitherto unrecognized link
between TGF-b signaling and the opposing effects of Tmeff1 on
BMP signaling at least at Smad1/5/8 phosphorylation events.
Given thewidespread importance of BMP signaling in controlling
adult SC quiescence and the need to restrict it upon SC activa-
tion, it will be interesting in the future to explore the extent to
which the mechanisms we have uncovered here might represent
a common theme in SC biology.
In closing, increasing numbers of reports have surfaced over
recent years describing both synergistic and antagonistic effects
between TGF-b and BMP signaling pathways (Wang and Hirsch-
berg, 2003; Yew et al., 2005; Izumi et al., 2006; Giacomini et al.,
2009;Wrighton et al., 2009; Keller et al., 2011). Indeed, these two
cognate pathways seem to be intertwined frequently, although
the outputs from their crosstalk are unpredictable. Our findings
now provide a functionally important example of this interplay
in SC biology and epithelial-mesenchymal crosstalk. In sifting
through the possible mechanisms and dissecting physiologically
relevant players, the pathway guided us to an interesting
example of a target gene induced selectively by one of these
signaling pathways that can potently impact the other signaling
pathway.
EXPERIMENTAL PROCEDURES
Mice, Beads Injection, and In Utero Lentiviral Injections
TbRII floxed mice (Leve´en et al., 2002) were crossed to K14-Cre (Vasioukhin
et al., 1999) and/or Rosa26YFPlox/stop/lox (Srinivas et al., 2001) mice. Other
mice were as published except for the Bmpr1afl/fl;K15-CrePGR;Rosa26YFP+/fl
cross. CD1 mice were from Charles River laboratories. Recombinant human
TGF-b1, -b2, and -b3 (50–100 ng, R&D systems), mouse Noggin (200 ng, R&D
systems), or BSA control was intradermally injected with FluoSpheres (Invitro-
gen). BrdU (50 mg/g) was injected intraperitoneally 12 and 24 hr before lethal
administration of CO2. Ultrasound-guided lentiviral injection and related proce-
dures have been described (Beronja et al., 2010). Two controls were used as
comparisons to knockdownmice: age- and sex-matcheduninjected littermates
and embryos infected with a nontargeting scrambled-shRNA, which activates
the endogenous microRNA processing pathway but is not known to target
any gene. All animals were maintained in an AAALAC-approved animal facility
and procedures were performed with IACUC-approved protocols.
Statistical Analysis
Data were analyzed and statistics performed (unpaired two-tailed Student’s
t test) in Prism5 (GraphPad). Significant differences between two groups
were noted by asterisks or actual p values.
ACCESSION NUMBER
Microarray data have been submitted to NCBI-GEO under accession number
GSE33471.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
doi:10.1016/j.stem.2011.11.005.
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